Total Xenoestrogen Body Burden in Relation to Mammographic Density, a Marker of Breast Cancer Rlisk
NCT ID: NCT00839696
Last Updated: 2019-11-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
270 participants
OBSERVATIONAL
2008-07-31
2010-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
MRI Parenchymal Enhancement: A New Marker of Breast Cancer Risk
NCT01649661
Study of Biomarkers in Tissue Samples From Patients With Breast Cancer
NCT01004796
Identification of Biomarkers in Women at High Risk or Average Risk of Breast Cancer
NCT00897416
Changes in Breast Density and Breast Cancer Risk in Women With Breast Cancer and in Healthy Women
NCT00445445
Biomarkers for Breast Cancer Risk in African American Women
NCT01736306
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
55 Years
70 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
United States Department of Defense
FED
University of Wisconsin, Madison
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Amy Trentham Dietz, PhD
Role: PRINCIPAL_INVESTIGATOR
Associate Professor- Population Health Sciences, UW School of Medicine and Public Health
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Wisconsin Hospital
Madison, Wisconsin, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
University of Wisconsin Carbone Cancer Center
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2008-1013
Identifier Type: OTHER
Identifier Source: secondary_id
A538500
Identifier Type: OTHER
Identifier Source: secondary_id
SMPH/POP HEALTH SCI
Identifier Type: OTHER
Identifier Source: secondary_id
CC07104
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.